Literature DB >> 21725703

Endocrine and metabolic aspects of the Wolfram syndrome.

Georgios Boutzios1, Sarantis Livadas, Evangelos Marinakis, Nicole Opie, Frangiskos Economou, Evanthia Diamanti-Kandarakis.   

Abstract

Wolfram syndrome (WS), also known as DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness), is a neurodegenerative disease with autosomal recessive inheritance with incomplete penetrance. DIDMOAD is a very rare disease with an estimated prevalence of 1 in 770,000 and it is believed to occur in 1 of 150 patients with juvenile-onset insulin-dependent diabetes mellitus. Additionally, WS may also present with different endocrine and metabolic abnormalities such as anterior and posterior pituitary gland dysfunction. This mini-review summarizes the variable presentation of WS and the need of screening for other metabolic and hormonal abnormalities, coexisting in this rare syndrome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21725703     DOI: 10.1007/s12020-011-9505-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  39 in total

1.  Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene.

Authors:  H Eiberg; L Hansen; B Kjer; T Hansen; O Pedersen; M Bille; T Rosenberg; L Tranebjaerg
Journal:  J Med Genet       Date:  2006-05       Impact factor: 6.318

2.  Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q.

Authors:  H El-Shanti; A C Lidral; N Jarrah; L Druhan; K Ajlouni
Journal:  Am J Hum Genet       Date:  2000-03-14       Impact factor: 11.025

3.  Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior.

Authors:  Adolfo Sequeira; Caroline Kim; Monique Seguin; Alain Lesage; Nadia Chawky; Alex Desautels; Michel Tousignant; Claude Vanier; Olivier Lipp; Chawki Benkelfat; Guy Rouleau; Gustavo Turecki
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-05-15       Impact factor: 3.568

4.  Juvenile diabetes mellitus, optic atrophy, sensory nerve deafness, and diabetes insipidus--a syndrome.

Authors:  T Gunn; R Bortolussi; J M Little; F Andermann; F C Fraser; M M Belmonte
Journal:  J Pediatr       Date:  1976-10       Impact factor: 4.406

5.  Wolframin mutations and hospitalization for psychiatric illness.

Authors:  M Swift; R G Swift
Journal:  Mol Psychiatry       Date:  2005-08       Impact factor: 15.992

6.  WFS1 gene mutation search in depressive patients: detection of five missense polymorphisms but no association with depression or bipolar affective disorder.

Authors:  T Ohtsuki; H Ishiguro; T Yoshikawa; T Arinami
Journal:  J Affect Disord       Date:  2000-04       Impact factor: 4.839

7.  Mutations in the WFS1 gene that cause low-frequency sensorineural hearing loss are small non-inactivating mutations.

Authors:  Kim Cryns; Markus Pfister; Ronald J E Pennings; Steven J H Bom; Kris Flothmann; Goele Caethoven; Hannie Kremer; Isabelle Schatteman; Karen A Köln; Tímea Tóth; Susan Kupka; Nikolaus Blin; Peter Nürnberg; Holger Thiele; Paul H van de Heyning; William Reardon; Dafydd Stephens; Cor W R J Cremers; Richard J H Smith; Guy Van Camp
Journal:  Hum Genet       Date:  2002-04-09       Impact factor: 4.132

8.  Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay.

Authors:  Alessia Colosimo; Valentina Guida; Luciana Rigoli; Chiara Di Bella; Alessandro De Luca; Silvana Briuglia; Liborio Stuppia; Damiano Carmelo Salpietro; Bruno Dallapiccola
Journal:  Hum Mutat       Date:  2003-06       Impact factor: 4.878

9.  Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein.

Authors:  T M Strom; K Hörtnagel; S Hofmann; F Gekeler; C Scharfe; W Rabl; K D Gerbitz; T Meitinger
Journal:  Hum Mol Genet       Date:  1998-12       Impact factor: 6.150

10.  The vasopressin precursor is not processed in the hypothalamus of Wolfram syndrome patients with diabetes insipidus: evidence for the involvement of PC2 and 7B2.

Authors:  B A Gabreëls; D F Swaab; D P de Kleijn; A Dean; N G Seidah; J W Van de Loo; W J Van de Ven; G J Martens; F W Van Leeuwen
Journal:  J Clin Endocrinol Metab       Date:  1998-11       Impact factor: 5.958

View more
  9 in total

1.  Clinical and molecular analysis of a Chinese family with autosomal dominant neurohypophyseal diabetes insipidus associated with a novel missense mutation in the vasopressin-neurophysin II gene.

Authors:  Yongfeng Luo; Binbin Wang; Yu Qiu; Chuan Zhang; Chengluo Jin; Yakun Zhao; Qingguo Zhu; Xu Ma
Journal:  Endocrine       Date:  2012-02-04       Impact factor: 3.633

2.  Clinical and molecular assessment of 13 Iranian families with Wolfram syndrome.

Authors:  Maryam Sobhani; Mohammad Amin Tabatabaiefar; Soudeh Ghafouri-Fard; Asadollah Rajab; Sarah Mozafarpour; Samaneh Nasrniya; Abdol-Mohammad Kajbafzadeh; Mohammad Reza Noori-Daloii
Journal:  Endocrine       Date:  2019-07-16       Impact factor: 3.633

3.  Natural history and clinical characteristics of 50 patients with Wolfram syndrome.

Authors:  Gema Esteban Bueno; Dyanne Ruiz-Castañeda; Javier Ruiz Martínez; Manuel Romero Muñoz; Pedro Carrillo Alascio
Journal:  Endocrine       Date:  2018-05-04       Impact factor: 3.633

4.  Diabetes mellitus, diabetes insipidus, optic atrophy, and deafness: A case of Wolfram (DIDMOAD) syndrome.

Authors:  Nasrollah Maleki; Bahman Bashardoust; Anahita Zakeri; Azita Salehifar; Zahra Tavosi
Journal:  J Curr Ophthalmol       Date:  2016-01-02

5.  A novel mutation of WFS1 gene leading to increase ER stress and cell apoptosis is associated an autosomal dominant form of Wolfram syndrome type 1.

Authors:  Yingying Gong; Li Xiong; Xiujun Li; Lei Su; Haipeng Xiao
Journal:  BMC Endocr Disord       Date:  2021-04-21       Impact factor: 2.763

6.  A mutant wfs1 zebrafish model of Wolfram syndrome manifesting visual dysfunction and developmental delay.

Authors:  G Cairns; F Burté; R Price; E O'Connor; M Toms; R Mishra; M Moosajee; A Pyle; J A Sayer; P Yu-Wai-Man
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

Review 7.  Urinary Tract Involvement in Wolfram Syndrome: A Narrative Review.

Authors:  Alberto La Valle; Gianluca Piccolo; Mohamad Maghnie; Giuseppe d'Annunzio
Journal:  Int J Environ Res Public Health       Date:  2021-11-15       Impact factor: 3.390

Review 8.  Role of the unfolded protein response in β cell compensation and failure during diabetes.

Authors:  Nabil Rabhi; Elisabet Salas; Philippe Froguel; Jean-Sébastien Annicotte
Journal:  J Diabetes Res       Date:  2014-04-09       Impact factor: 4.011

9.  Inspissated bile syndrome in an infant with citrin deficiency and congenital anomalies of the biliary tract and esophagus: identification and pathogenicity analysis of a novel SLC25A13 mutation with incomplete penetrance.

Authors:  Han-Shi Zeng; Shu-Tao Zhao; Mei Deng; Zhan-Hui Zhang; Xiang-Ran Cai; Feng-Ping Chen; Yuan-Zong Song
Journal:  Int J Mol Med       Date:  2014-09-10       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.